Amgen, CRISPR, Moderna, Sarepta and Vertex are included in this Analyst Blog.…
Shares of Moderna, BioNTech, Novavax, GSK and Pfizer fell on Tuesday following the vote.…
New York (www.aktiencheck.de) - Rating-Update:
Die Analysten von TD Cowen bewerten die Aktie von Moderna Inc. (ISIN: US60770K1079, WKN: A2N9D9, Ticker-Symbol:…
…
…
Modern application of Talmudic principles using ETFs focuses on balancing growth and income. Check out the Talmudic investment strategy here.…
New York (www.aktiencheck.de) - Rating-Update:
Die Analysten von Evercore ISI stufen die Aktie von Moderna Inc. (ISIN: US60770K1079, WKN: A2N9D9, Ticker-Symbol:…
New York (www.aktiencheck.de) - Moderna-Aktienanalyse von Goldman Sachs:
1. Hintergrund der Herabstufung
Goldman Sachs hat die Aktie von Moderna Inc. (ISIN: US60770K1079,…
It can be exciting to buy a stock that has been red hot and to jump on the bandwagon --…
Kulmbach (www.aktiencheck.de) - Moderna-Aktienanalyse von "Der Aktionär":
Lars Friedrich vom Anlegermagazin "Der Aktionär" nimmt in einer aktuellen Aktienanalyse die Aktie von…
Analyst Salveen Richter downgraded shares of the biotech company from neutral to buy and significantly lowered her price target.…
Here are Wednesdays biggest calls on Wall Street.…
Goldman Sachs cuts Moderna stock rating, slashes target to $51…
Moderna stock rises following RFK Jrs comments…
Based on its share price, down 75% in the last three years, its easy to write off Moderna (NASDAQ: MRNA)…
If a stock is near its 52-week low, it may be a great time to buy it on the dip,…
Für den mRNA-Spezialisten Moderna (MRNA) war die Corona-Pandemie die große Zeit. Mit dem Abebben der Pandemie brach die Nachfrage ein.…
IRW-PRESS: Moderna Inc.: Moderna erhält den Zuschlag für die Belieferung der Europäischen Union mit seinem COVID-19-mRNA-ImpfstoffDie Vereinbarung bietet den teilnehmenden…
IRW-PRESS: Moderna Inc.: Moderna erhält den Zuschlag für die Belieferung der Europäischen Union mit seinem COVID-19-mRNA-Impfstoff
Die…
Moderna secures tender to supply COVID-19 vaccine in EU, Norway, and North Macedonia…
Moderna is testing a norovirus vaccine in a phase three trial. Results could be available as soon as this year.…
Plus: Moderna’s bird flu vaccine, Obamacare enrollment breaks records, and AstraZeneca’s new breast cancer treatment is FDA approved.…
Moderna stock jumps on AI healthcare prospects…
These are the stocks posting the largest moves in midday trading.…
As Moderna (NASDAQ: MRNA) looks to shore up its business in the wake of its declining coronavirus vaccine sales, its…
…
Exchange-traded funds (ETFs) are great additions to any portfolio. I use them to gain exposure to market segments where I…
Share prices of Moderna (NASDAQ: MRNA) plummeted 58% in 2024, ranking among the worst performers in the S&P 500 index.…
Returning 25% in 2024, the S&P 500 delivered a record-breaking year for stock market investors. A resilient global economy coupled…
Moderna stock surges on bird flu vaccine funding…
The U.S. government has awarded Moderna $590 million to advance the late-stage development of its mRNA bird flu vaccine, as…
Although the stock market was having a generally strong week, that isnt the case for vaccine technology company Moderna (NASDAQ:…
Moderna (NASDAQ: MRNA) was one of the hottest companies of early pandemic times, delivering a coronavirus vaccine to market in…
Moderna (NASDAQ: MRNA) shareholders have been having a rough time lately. The biotech stock rocketed higher last spring, but the…
…
New York (www.aktiencheck.de) - Moderna-Aktienanalyse von Morgan Stanley:
Rating und Kursziel
Morgan Stanley-Analyst Terence Flynn senkt das Kursziel für die Aktie von…
A bad seven-month stretch just got worse for Moderna (NASDAQ: MRNA). The messenger RNA (mRNA) pioneer provided a business and…
Shares hit another skid on Jan. 13 when the company cut its guidance for 2024 and 2025.…
All three of the major indexes are moving higher. Investors have been watching inflation reports closely, including the December PPI…
Dow, S&P 500, and Nasdaq futures are rising in premarket trading Tuesday as the stock market digests a report on…
Zum Wochenauftakt schloss der DAX 0,41 Prozent tiefer bei 20.132 Punkten. Heute steht der Leitindex vor Herausforderungen durch gemischte Vorgaben…
The crash in MRNA stock comes after the company slashed its outlook for 2024 and 2025 sales and also announced…
These are the stocks posting the largest moves in midday trading.…
Modernas (NASDAQ: MRNA) sales are slowing down, and Moderna stock is going down -- a lot.
The coronavirus vaccine makers shares…
…
…
Keinen Grund zur Freude haben Inhaber dem Anteilsschein von Moderna : Der Kurs des Papiers sackt kräftig ab. Jahreschart der…
Kulmbach (www.aktiencheck.de) - Moderna-Aktienanalyse von "Der Aktionär":
Thomas Bergmann vom Anlegermagazin "Der Aktionär" nimmt in einer aktuellen Aktienanalyse die Aktie von…
Moderna now expects 2025 revenue to come in between $1.5 billion and $2.5 billion, most of which will come in…
Moderna Inc (NASDAQ:MRNA, ETR:0QF) shares plunged almost 20% after the drugmaker pre-announced fiscal 2024 sales below expectations. The company expects...…